Ohmx

Ohmx

Leuven, Belgium· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

Ohmx is a Leuven-based omics service provider specializing in genomics, transcriptomics, epigenomics, proteomics, and single-cell sequencing for both research and clinical diagnostics. It differentiates itself through a strong focus on data quality (ISO-certified), a personalized client partnership model, and deep scientific expertise rooted in academia. The company serves pharmaceutical, biotech, and academic clients, offering end-to-end project management from experimental design to advanced bioinformatics.

OncologyOther (Broad Research & Biologics)

Technology Platform

Multi-omics service platform centered on Oxford Nanopore long-read sequencing, complemented by short-read, single-cell, proteomics (mass spectrometry), and translatomics (ribosome profiling). Integrated with advanced bioinformatics and AI/ML for custom data analysis, all underpinned by an ISO-certified quality management system.

Funding History

1
Total raised:$3.5M
Seed$3.5M

Opportunities

Growing demand for complex multi-omics data in translational research and precision medicine.
Significant opportunity in the biopharma sector for quality control of advanced therapies using long-read sequencing.
Potential to develop more standardized software or diagnostic tools from their service expertise.

Risk Factors

High dependence on Oxford Nanopore technology and intense competition in the omics CRO market.
The personalized service model may face scalability challenges.
Retention of specialized scientific and bioinformatics talent is critical in a competitive hub.

Competitive Landscape

Competes with large, global CROs (e.g., Eurofins, Azenta), academic core facilities, and other specialized omics service providers. Differentiates through a strong focus on long-read sequencing applications, a partnership-oriented model, deep academic ties, and an emphasis on data quality and custom bioinformatics.